Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$25.04 - $30.06 $2 Million - $2.4 Million
-80,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $2.19 Million - $2.62 Million
80,000 New
80,000 $2.35 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.33B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Kamunting Street Capital Management, L.P. Portfolio

Follow Kamunting Street Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.